Sperm counts largely stable after adjuvant treatment of clinical stage I testicular cancerMarch 1, 2019Genitourinary CancerOncology
First-line avelumab/axitinib for RCC benefits wide range of patientsFebruary 21, 2019Genitourinary CancerImmuno-oncology
Poor-prognosis cancers linked to highest suicide risk in first yearJanuary 7, 2019OncologyBreast CancerGenitourinary CancerLung CancerMelanomaMental HealthPulmonology
Abiraterone also benefits low-risk metastatic prostate cancer patientsNovember 13, 2018Genitourinary Cancer
Checkpoint inhibitor/TKI combo improves PFS of RCC over sunitinibOctober 22, 2018Genitourinary CancerImmuno-oncology
SU2C announces researcher-industry collaboration on immunotherapyJuly 13, 2016Genitourinary CancerMelanomaMultiple MyelomaImmuno-oncology
Pembrolizumab paired with immunostimulator is safe and tolerableJune 15, 2016Genitourinary CancerLung CancerImmuno-oncology
